Literature DB >> 18315774

Basic pharmacology relevant to drug abuse assessment: tramadol as example.

R B Raffa1.   

Abstract

Tramadol is a centrally acting analgesic in widespread use throughout the world. Although there is extensive preclinical, clinical, post-marketing and epidemiological data indicating relatively low--but not zero--abuse/dependence, questions continue to arise about its abuse potential and appropriate regulatory classification. This article considers these questions from the point of view of the basic pharmacology of tramadol. There is nothing unique about tramadol in this regard, but its multimodal mechanism of action, pharmacologically active enantiomers, and active metabolite make it a particularly instructive and relevant example.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18315774     DOI: 10.1111/j.1365-2710.2008.00897.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  23 in total

Review 1.  Implications of opioid analgesia for medically complicated patients.

Authors:  Howard Smith; Patricia Bruckenthal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.

Authors:  Miriam Z Mintzer; Ryan K Lanier; Michelle R Lofwall; George E Bigelow; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2010-06-09       Impact factor: 4.492

3.  Physician's role in prescribing opioids in developing countries.

Authors:  Jorge A Roa; Alexandra Guevara; Carolina Guevara; Jaime Guevara-Aguirre
Journal:  BMJ Case Rep       Date:  2019-06-02

4.  Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment.

Authors:  William W Stoops; Michelle R Lofwall; Paul A Nuzzo; Lori B Craig; Anthony J Siegel; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2012-05-24       Impact factor: 4.530

5.  Tramadol Dependence: A Case Report.

Authors:  J Prakash; R Saini
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Evaluation of molecular descriptors and HPLC retention data of analgesic and anti-inflammatory drugs by factor analysis in relation to their pharmacological activity.

Authors:  Marcin Koba; Jolanta Stasiak; Leszek Bober; Tomasz Baczek
Journal:  J Mol Model       Date:  2010-02-01       Impact factor: 1.810

7.  Physical dependence potential of daily tramadol dosing in humans.

Authors:  Ryan K Lanier; Michelle R Lofwall; Miriam Z Mintzer; George E Bigelow; Eric C Strain
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

8.  Discriminative stimulus effects of tramadol in humans.

Authors:  Angela N Duke; George E Bigelow; Ryan K Lanier; Eric C Strain
Journal:  J Pharmacol Exp Ther       Date:  2011-04-05       Impact factor: 4.030

9.  The molecular and biochemical insight view of lycopene in ameliorating tramadol-induced liver toxicity in a rat model: implication of oxidative stress, apoptosis, and MAPK signaling pathways.

Authors:  Kadry M Sadek; Mohamed A Lebda; Tarek K Abouzed; Sherif M Nasr; Yasser El-Sayed
Journal:  Environ Sci Pollut Res Int       Date:  2018-09-24       Impact factor: 4.223

10.  Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice.

Authors:  Atsushi Nakamura; Minoru Narita; Kan Miyoshi; Keiko Shindo; Daiki Okutsu; Masami Suzuki; Kimio Higashiyama; Tsutomu Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2008-08-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.